Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Seragnoli

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|June 9, 2021
[Microdosing LSD: practices and risks]Federico Seragnoli, Daniel Pires Martins, Gabriel Thorens
Current Topics in Behavioral Neurosciences|October 22, 2024
Insights from Ecstatic Epilepsy: From Uncertainty to Metacognitive FeelingsNina M Sooter, Federico Seragnoli, Fabienne Picard
La Revue Du Praticien|January 23, 2026
[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]Michel Sabé, Federico Seragnoli, Louise Penzenstadler, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2023
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factorsPolina Ponomarenko, Federico Seragnoli, Abigail Calder, et al.
Revue Medicale Suisse|August 23, 2023
[Ethics in the practice of psychedelic-assisted psychotherapy]Gabriel Thorens, Louise Penzenstadler, Federico Seragnoli, et al.
Therapeutic Advances in Psychopharmacology|May 25, 2026
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physiciansKristian Beichmann, Polina Catzeflis, Helena D Aicher, et al.
Revue Medicale Suisse|January 14, 2021
[What's new in addiction medicine]Daniele Zullino, Jean-Bernard Daeppen, Federico Seragnoli, et al.
Journal of Psychiatry & Neuroscience : JPN|July 25, 2025
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case reportMichel Sabé, Federico Seragnoli, Gabriel Thorens, et al.
Drug and Alcohol Dependence Reports|June 4, 2026
Who uses legal cannabis and why? Cluster profiles of participants in a Swiss regulated sales pilot trialMaëlle Dreifuss Bisson, Tamara Corino, Tatiana Aboulafia Brakha, et al.
Journal of Clinical Psychology|November 4, 2021
Lessening of the pervasiveness of interpersonal patterns in borderline personality disorder explains symptom decrease after treatment: A process analysisUeli Kramer, Hélène Beuchat, Loris Grandjean, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|June 9, 2021
[Microdosing LSD: practices and risks]Federico Seragnoli, Daniel Pires Martins, Gabriel Thorens
Current Topics in Behavioral Neurosciences|October 22, 2024
Insights from Ecstatic Epilepsy: From Uncertainty to Metacognitive FeelingsNina M Sooter, Federico Seragnoli, Fabienne Picard
La Revue Du Praticien|January 23, 2026
[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]Michel Sabé, Federico Seragnoli, Louise Penzenstadler, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2023
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factorsPolina Ponomarenko, Federico Seragnoli, Abigail Calder, et al.
Revue Medicale Suisse|August 23, 2023
[Ethics in the practice of psychedelic-assisted psychotherapy]Gabriel Thorens, Louise Penzenstadler, Federico Seragnoli, et al.
Therapeutic Advances in Psychopharmacology|May 25, 2026
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physiciansKristian Beichmann, Polina Catzeflis, Helena D Aicher, et al.
Revue Medicale Suisse|January 14, 2021
[What's new in addiction medicine]Daniele Zullino, Jean-Bernard Daeppen, Federico Seragnoli, et al.
Journal of Psychiatry & Neuroscience : JPN|July 25, 2025
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case reportMichel Sabé, Federico Seragnoli, Gabriel Thorens, et al.
Drug and Alcohol Dependence Reports|June 4, 2026
Who uses legal cannabis and why? Cluster profiles of participants in a Swiss regulated sales pilot trialMaëlle Dreifuss Bisson, Tamara Corino, Tatiana Aboulafia Brakha, et al.
Journal of Clinical Psychology|November 4, 2021
Lessening of the pervasiveness of interpersonal patterns in borderline personality disorder explains symptom decrease after treatment: A process analysisUeli Kramer, Hélène Beuchat, Loris Grandjean, et al.
Pageof 2